{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:30:27Z","timestamp":1777451427945,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Shire Human Genetic Therapies Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ghir.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T19:02:27Z","timestamp":1504206147000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Continuous longitudinal infusion of rhIGF-1\/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study"],"prefix":"10.1016","volume":"36","author":[{"given":"Ingrid","family":"Hansen-Pupp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina","family":"Tocoian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerissa C.","family":"Kreher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boubou","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2017.08.004_bb0005","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/humrep\/13.5.1389","article-title":"Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy","volume":"13","author":"Langford","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ghir.2017.08.004_bb0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/apa.13350","article-title":"Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development","volume":"105","author":"Hellstr\u00f6m","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2017.08.004_bb0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1203\/PDR.0b013e3182115000","article-title":"Influence of insulin-like growth factor 1 and nutrition during phases of postnatal growth in very preterm infants","volume":"69","author":"Hansen-Pupp","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2017.08.004_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-3782(86)90096-4","article-title":"Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally","volume":"13","author":"Lineham","year":"1986","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.ghir.2017.08.004_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"1","author":"Blencowe","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2017.08.004_bb0030","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamaophthalmol.2016.0391","article-title":"Ophthalmologic outcome of extremely preterm infants at 6.5years of age: Extremely Preterm Infants in Sweden Study (EXPRESS)","volume":"134","author":"Hellgren","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ghir.2017.08.004_bb0035","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2017.08.004_bb0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1203\/PDR.0b013e3181973dc8","article-title":"Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration","volume":"65","author":"Vanhaesebrouck","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2017.08.004_bb0045","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor 1 deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstr\u00f6m","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2017.08.004_bb0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1651-2227.2009.01677.x","article-title":"Serum levels of IGF1 are a useful predictor of retinopathy of prematurity","volume":"99","author":"P\u00e9rez-Mu\u00f1uzuri","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2017.08.004_bb0055","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1542\/peds.2005-1926","article-title":"Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit","volume":"117","author":"L\u00f6fqvist","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2017.08.004_bb0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1651-2227.2012.02826.x","article-title":"WINROP Consortium Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)","volume":"101","author":"L\u00f6fqvist","year":"2012","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2017.08.004_bb0065","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2017.08.004_bb0070","first-page":"753","article-title":"Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates","volume":"121","author":"Guler","year":"1989","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2017.08.004_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/pr.2012.146","article-title":"Longitudinal infusion of a complex of insulin-like growth factor-1 and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety","volume":"73","author":"Ley","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2017.08.004_bb0080","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1210\/jc.2004-0243","article-title":"Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-1\/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes","volume":"89","author":"Saukkonen","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.004_bb0085","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jc.2005-1017","article-title":"Pharmacokinetic studies of recombinant human insulin-like growth factor 1 (rhIGF-1)\/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome","volume":"91","author":"Camacho-Hubner","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.004_bb0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00000658-200002000-00014","article-title":"Insulinlike growth factor 1 plus insulin like growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children","volume":"231","author":"Jeschke","year":"2000","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ghir.2017.08.004_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1203\/PDR.0b013e31819d9e8c","article-title":"A pharmacokinetic and dosing study of intravenous insulin-like growth factor-1 and IGF-binding protein-3 complex to preterm infants","volume":"65","author":"L\u00f6fqvist","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2017.08.004_bb0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/pr.2016.255","article-title":"Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1\/rhIGFBP-3 in preterm infants","volume":"81","author":"Chung","year":"2017","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2017.08.004_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2008-1293","article-title":"Fresh-frozen plasma as a source of exogenous insulin-like growth factor-I in the extremely preterm infant","volume":"94","author":"Hansen-Pupp","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.004_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/17425255.4.3.311","article-title":"Mecasermin rinfabate: rhIGF-1\/rhIGFBP-3 complex: iPLEX","volume":"4","author":"Williams","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ghir.2017.08.004_bb0115","first-page":"553","article-title":"Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency","volume":"5","author":"Fintini","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ghir.2017.08.004_bb0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clp.2013.02.002","article-title":"The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment","volume":"40","author":"Smith","year":"2013","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.ghir.2017.08.004_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpeds.2010.04.032","article-title":"Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study","volume":"157","author":"Beardsall","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2017.08.004_bb0130","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.297.6659.1304","article-title":"Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia","volume":"297","author":"Lucas","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ghir.2017.08.004_bb0135","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","article-title":"Long-term treatment with recombinant insulin-like growth factor (IGF)-1 in children with severe IGF-1 deficiency due to growth hormone insensitivity","volume":"92","author":"Chernausek","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.08.004_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1542\/peds.113.3.537","article-title":"Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants","volume":"113","author":"Mitanchez-Mokhtari","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2017.08.004_bb0145","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jpeds.2013.12.046","article-title":"Relationship between insulin-like growth factor 1 levels, early insulin treatment, and clinical outcomes of very low birth weight infants","volume":"164","author":"Beardsall","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2017.08.004_bb0150","series-title":"Selected Abstracts of the 1st Congress of joint European Neonatal Societies (jENS 2015); Budapest (Hungary); September 16\u201320, 2015","article-title":"Risk assessment based on an experimental model to evaluate compatibility of recombinant igf-1\/igfbp-3 with intravenous medications commonly administered in the neonatal environment","volume":"4","author":"Turner","year":"2015"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:50:24Z","timestamp":1761087024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637417300746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"alternative-id":["S1096637417300746"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2017.08.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous longitudinal infusion of rhIGF-1\/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}